RBCC Announces Global Marketing Initiative

Share
NOKOMIS, Fla.--(BUSINESS WIRE)--

Rainbow Coral Corp. (OTCBB: RBCC) has ambitious plans for 2012. Not only is the company working diligently to complete its acquisition of Nano3D Biosciences (n3D), but developing a business plan to market the breakthrough Bio-Assembler system to cell researchers around the world, as well.

“To succeed in biotechnology, it's necessary to think globally,” said RBCC CEO Patrick Brown.

The global biotech industry, led by companies in the U.S., is expected by many to grow to about $103 billion by 2013. The predicted growth is largely due to rising technology innovation and improving healthcare infrastructure worldwide. In the Bio-Assembler, RBCC believes it will have a breakthrough product with a truly global market.

“This system allows researchers to grow and study lifelike, 3D cell structures more easily and affordably than ever before,” Brown said. “That's going to be especially crucial in emerging economies where research dollars are scarcer than in the U.S. We want to market and distribute this technology to researchers from China to Brazil to South Africa.”

For more information on Rainbow BioSciences, RBCC's biotechnology division, please visit www.rainbowbiosciences.com/investors.

Rainbow BioSciences is working to develop new medical and research technology innovations to compete alongside companies such as Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) Affymax, Inc. (NASDAQ: AFFY) and Celgene Corp. (NASDAQ: CELG).

Follow us on Twitter at www.twitter.com/RBCCinfo.

About Rainbow BioSciences

Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB: RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.rainbowbiosciences.com]. For investment information and performance data on the company, please visit www.RainbowBioSciences.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Rainbow Coral Corp.
Patrick Brown, 813-367-9511
President and CEO
info@rainbowcoral.com



 
 
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust